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While group1 metabotropic glutamate receptors (mGluRs) and ionotropic NMDA receptors regulate 
nociception, the precise molecular mechanism(s) contributing to glutamate signaling in chronic pain remain 
unclear. Here we not only confirmed the key involvement of Homer proteins in neuropathic pain, but also 
distinguished between the functional roles for different Homer family members and isoforms. Chronic 
constriction injury (CCI) of the sciatic nerve induced long-lasting, time-dependent increases in the 
postsynaptic density expression of the constitutively expressed (CC) isoforms Homer1b/c and/or Homer2a/b 
in the spinal dorsal horn and supraspinal structures involved in nociception (prefrontal cortex, thalamus), 
that co-occurred with increases in their associated mGluRs, NR2 subunits of the NMDA receptor and the 
activation of downstream kinases. Virus-mediated over-expression of Homer1c and Homer2b after spinal 
(intrathecal) virus injection exacerbated CCI-induced mechanical and cold hypersensitivity however 
Homer1 and Homer2 gene knock-out (KO) mice displayed no changes in their neuropathic phenotype. In 
contrast, over-expression of the immediate early gene (IEG) Homer1a isoform reduced, while KO of 
Homer1a gene potentiated neuropathic pain hypersensitivity. Thus, nerve injury-induced increases in CC-
Homers expression promote pain in pathological states, but IEG-Homer induction protects against both the 
development and maintenance of neuropathy. Additionally, exacerbated pain hypersensitivity in transgenic 
mice with reduced Homer binding to mGluR5 supports also an inhibitory role for Homer interactions with 
mGluR5 in mediating neuropathy. Such data indicate that nerve injury-induced changes in glutamate 
receptor/Homer signaling contribute in dynamic but distinct ways to neuropathic pain processing, which has 
relevance for the etiology of chronic pain symptoms and its treatment.  
 







1. Introduction  
Peripheral nerve injury leads to the development of neuropathic pain as a consequence of injury-induced 
central sensitization. This involves increases in excitatory neuronal firing, glutamate release within 
peripheral and central nervous systems, and subsequent reorganization of the nociceptive network [e.g. 
9,31,32]. Glutamate transmission, particularly through the Gq/o-coupled Group1 metabotropic glutamate 
receptors (mGluR1/5), as well as (or in conjunction with) ionotropic NMDA glutamate receptors, has been 
highly implicated in nociception [e.g. 7,16,45,72]. Thus, a likely molecular candidate contributing to 
changes in spinal and supraspinal glutamate signaling in chronic pain is the Homer family of proteins, which 
constitutes a part of the signaling scaffold regulating the trafficking, clustering and function of both Group1 
mGluRs and NMDA receptors [e.g. 13,14,53].  
 
Homer proteins are encoded by 3 genes (Homer1,2,3) that give rise to constitutively expressed, coiled-coiled 
(CC; Homer1b/c/d/g/h, Homer2a/b and Homer3; a.k.a. CC-Homers) and immediate early gene (IEG) 
products (from Homer1, Homer1a and ania-3) [13,14]. In contrast to CC-Homers, IEG Homers lack the CC-
domain and are incapable of multimerization or multi-protein interactions. Thus, their induction upon 
synaptic activity destabilizes CC-Homer interactions (including those with glutamate receptors), enabling 
synaptic rearrangement [6,26]. While the role for Homer proteins in regulating both pre- and postsynaptic 
aspects of glutamate signaling is well-characterized [e.g. 53] and tissue/nerve injury-induced adaptations 
within glutamate signaling were shown to be critically involved in the development and maintenance of 
chronic pain [7,16,45,72], there is recently a growing line of evidence implicating Homer proteins in the 
regulation of nociception. Homer proteins are expressed in brain regions conveying nociceptive information 
[e.g. 33,53,56], as well as in the spinal dorsal horn neurons that receive sensory input [36,40,57,71]. Both 
IEG-Homer1a and CC-Homer1b/c are selectively up-regulated in the spinal dorsal horn neurons in model of 
chronic inflammatory pain and the manipulation of their protein levels alters inflammation-induced 
mechanical and thermal hyperalgesia [57,71]. While Homer1a induction and increased Homer1b/c exhibit 
distinct temporal profiles within the spinal dorsal horn following chronic constriction injury (CCI) of the 
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sciatic nerve [36,37,40] or chronic compression of dorsal root ganglion [35], the functional relevance of 
changes in Homers expression has been examined to date only in the early stage (4 h after CCI) of the 
development of neuropathic pain [36].  
 
Thus, in the present study, we used a combination of genetics and immunoblotting approaches to further 
confirm the important role for Homer proteins in regulating pain sensitivity and more importantly to 
delineate the relative functional roles played by different Homer family members and isoforms in the 
development and maintenance of neuropathic pain in mice. We first determined the profile of changes in 
Homer proteins expression after CCI together with injury-induced alterations in the protein level/activation 
of Homers-associated mGluRs (mGluR1a/5) and downstream kinases (PKC, PI3K and ERK1/2) within 
structures involved in nociception. Next, we examined the effects of Homers overexpression after spinal 
(intrathecal) delivery and the global Homers deficiency on both the development and maintenance states of 
CCI-induced neuropathic pain. Finally, we investigated whether the mGluR5-Homer proteins interaction 








2. Material and Methods 
2.1. Subjects 
C57BL/6J mice. The expression of the CC-Homer isoform Homer1b/c is up-regulated within spinal cord 
dorsal horn following sciatic nerve ligation [36,37]. Thus, immunoblotting experiments extended these 
earlier data to another CC-Homer isoform, Homer2a/b, and related changes in CC-Homer expression to 
those of their associated Group1 mGluRs (mGluR1a/5) and the NR2a/b subunits of the NMDA receptor, as 
well as to the activational state of downstream kinases (ERK1/2, PKC and PI3K) to determine whether or 
not chronic constriction injury (CCI) of the sciatic nerve induces changes in the spinal and supraspinal 
expression/activation of Group1 mGluR/Homer signaling pathways. Follow-up behavioral experiments then 
assayed for the functional relevance of observed changes in Homer protein expression for neuropathic pain 
hypersensitivity. All of these studies employed adult male C57BL/6J (B6) mice (8 weeks of age; 25–30 g; 
the Jackson Laboratories, Bar Harbor, ME). B6 mice were allowed to acclimate to the colony
 
room for at 
least 7 days after arrival and were housed in polyethylene cages (4-5 per cage), in a room controlled for 
temperature (25°C) and humidity (71%) under a regular 12-h day/night cycle (lights on at 7:00 A.M.; lights
 
off at 7:00 P.M.). Standard laboratory rodent chow and water were available ad libitum. Animals were 
habituated to testing procedures for at least 3-4 days before experiments. The handling and testing of the 
animals were conducted during the light phase, between 9:00 a.m. and 2:00 p.m. Every effort was made to 
minimize the number of animals used in the study. Experimental
 
protocols were approved by the 
Institutional Animal Care and
 
Use Committee of our respective institutions and were consistent
 
with the 
guidelines provided by the National Institute of Health
 
(NIH) Guide for Care and Use of Laboratory 
Animals (NIH publication
 
number 80-23, revised 1996) and the guidelines of the Committee for Research 
and Ethical Issues of IASP published in [75]. 
  
Homer Knock-out (KO) mice. Our immunoblotting data revealed time-dependent increases in Homer1b/c 
and Homer2a/b expression following CCI (Fig. 1) and earlier studies indicated an important role for 
Homer1a in regulating inflammatory pain [50]. Thus, we employed a knock-out (KO) strategy to confirm a 
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necessary role for IEG and CC-Homer isoforms (Homer1a, Homer1, Homer2) in the development and 
maintenance of neuropathic pain following CCI. For this, the behavior of Homer1a, Homer1, and Homer2 
gene KO mice was compared to their respective wild-type (WT) and heterozygous (HET) mutant mice. WT, 
HET and KO littermates from all 3 KO lines were bred in-house at the University of California Santa 
Barbara Biology II vivarium from mating of heterozygous breeder pairs (B6 X 129Xi/SvJ background). 
Details of the generation of these mice are provided in Hu et al. [21] for Homer1a KO, Yuan et al. [73] for 
Homer1 KO and Shin et al. [49] for Homer2 KO. WT, HET and KO littermate pups from a minimum of 4 
different litters for each line were used for each replicate of the behavioral studies to avoid litter confounds. 
Experimental mice were transferred to the Psychology vivarium at approximately 5 weeks of age and 
allowed to acclimate to the housing conditions for 2-3 weeks prior to surgery and behavioral testing. All 
experimental procedures involving WT, HET and KO mice were conducted on male littermate mice, 7-8 
weeks of age, housed and handled under conditions described for the B6 mice above.  
 
mGluR5 transgenic (Tg) mice. Our immunoblotting data indicated the co-regulation of CC-Homer 
expression and mGluR5 by CCI (Fig. 1). Thus, we examined the functional relevance of mGluR5-Homer 
interactions
 
in neuropathic pain by assaying the pain hypersensitivity of a transgenic
 
(Tg) mouse with a 
phenylalanine (F) arginine (R) point mutation
 
within the Homer binding domain on mGluR5 at amino acid 
position 1128 (mGluR5
F1128R
) that impairs the capacity of Homer proteins to physically interact with the 
receptor [12,61], but does not affect the total protein expression of either mGluR5 or Homers [12]. The 
generation of Tg littermates and all experiments procedures involving WT, HET and Tg mice were 
conducted as described for B6 and KO mice above.  
 
2.2. Induction and assessment of neuropathic pain 
Sciatic nerve injury. B6 mice, homozygous and heterozygous KO/Tg mice, as well as their WT counterparts, 
were subjected to peripheral neuropathy induced by chronic constriction injury (CCI) of the sciatic nerve as 
described by Bennett and Xie [4], with slight modifications for mice [42,45]. The sciatic nerve injury was 
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performed under isoflurane anesthesia delivered via a nose cone (2% isoflurane with oxygen as the carrier 
gas). The skin was shaved and an incision was made just below the right hipbone, parallel to the sciatic 
nerve. The biceps femoris and the gluteus superficialis were separated, and the right sciatic nerve was 
exposed. Proximal to the sciatic trifurcation, the injury was produced by three loose ligations around the 
sciatic nerve. The ligatures (4/0 silk) were tied loosely around the nerve with 1 mm spacing, until they elicit 
a brief twitch in the respective hindlimb, which prevented from applying a too strong ligation. The total 
length of nerve affected was 3-4 mm. Mechanical and cold sensitivity was assessed before sciatic nerve 
ligation (as basal pain threshold) and then every 2
nd
 day for 2 weeks following the injury using the 
procedures outlined below. Mechanical sensitivity was also confirmed in all neuropathic B6 mice employed 
in the immunoblotting studies. In all experiments, the observer was not aware of the treatment.  
 
Mechanical sensitivity. Mechanical sensitivity was assessed by measuring the withdrawal threshold of the 
paw ipsilateral to the site of ligation in response to mechanical stimuli using von Frey filaments (Stoelting, 
Wood Dale, IL, USA). Animals were placed in a plastic cage with a wire net floor and were allowed to 
habituate 20 min before the testing began. Animals were also habituated over a period of 2-3 consecutive 
days by recording a series of baseline measurements. The filaments were applied in ascending order, each 
three times at an interval of 3-5 seconds to the midplantar surface of the hindpaw as described previously 
[42,45] and the smallest filament eliciting a foot withdrawal response was considered the threshold stimulus. 
Each animal was tested 2-3 times at the interval of 10 min to determine the mean threshold at the respective 
time points. The strength of the von Frey stimuli ranged from 0.07 to 6.0g.  
 
Cold sensitivity. For assessment of cold sensitivity, the acetone test was used as described previously [42]. 
Mice were tested for paw withdrawal response to a cold stimulus using a 50 µl drop of acetone applied with 
a syringe fitted with a blunted needle at the centre of the plantar surface of a hindpaw ipsilateral to the site of 
ligation. Acetone was applied alternatively twice with 5 min between each application and the responses 
scored categorically. Responses were monitored for 1 min after application and were graded to the following 
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4-point scale: 0, no response; 1, quick withdrawal, foot lifted and/or light shakes; 2, prolonged withdrawal 
and/or prolonged shake of the paw; 3, repeated flicking of the paw with licking directed at the ventral side of 
the paw.  
 
Basal pain threshold. Basal pain threshold was assessed by measuring response latencies to mechanical 
stimuli as described above, as well as to a thermal stimulus using the hot water (54°C) tail-immersion assay, 
as described by Stone et al. [52]. Briefly, mice were gently wrapped in a soft cloth such that their tails were 
exposed, and three-quarters of the length of the tail was dipped into the hot water. The response was defined 
as the removal of the tail from the hot water in sec.  
 
2.3. Modification of pain sensitivity by intrathecal microinjection of AAVs carrying Homer cDNA 
The procedure for generating recombinant AAV vectors carrying the hrGFP cDNA or the hemagglutinin 
(HA) tag fused to the coding region of rat Homer1a, Homer1c and Homer2b have been described in detail 
elsewhere [e.g., 29] and were the same as those used in previously published studies 
[e.g.17,29,33,53,54,56,57]. The procedure for infusing AAVs into the spinal was very similar to [59]. In the 
present experiments, mice were anesthetized with isoflurane delivered via a nose cone (2% isoflurane with 
oxygen as the carrier gas). For more precise AAV application, a caudal cutaneous incision (1 cm) of the 
shaved skin above the spinal cord was made with a scalpel and a 27-gauge needle, connected to PE tubing 
and a microprocessor-controlled minipump (World Precision Instruments), secured in place using a 
manipulator arm and the AAV vectors were infused at a rate of 0.05 l/min for 5 min (total volume = 0.25 
l). Following the 5-min infusion period, the needle was left in place for an additional 5 min and then 
removed very slowly. Then, the incision site was sutured shut and animals were left undisturbed for 3 weeks 
when AAV-mediated transgene expression peaks remained at stable levels [e.g. 29,30]. Following 
behavioral testing, animals were deeply anesthesized, transcardially perfused with phosphate-buffered 
saline, followed by paraformaldehyde. 80 m-thick sections of the spinal cord (L2-L6; vibratome) were 
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examined for assessment of transduction efficiency and vector spread based on hrGFP-epifluorescence or 
immunohistochemical detection of the (HA)-tag. 
  
2.4. Evaluation of the subcellular distribution of protein expression/activational state of members of mGluR-
Homer-kinase signaling pathways  
Subcellular fractionation procedures. Evidence indicates that sciatic nerve ligation produces a shift in the 
relative PSD expression of Homer1a versus Homer1b/c within the ipsilateral spinal cord at 4 h post-injury 
[36,37,40]. Thus, we conducted an immunoblotting study upon both spinal and supraspinal tissue to 
determine whether or not injury-induced shifts in the subcellular distribution of Homer1 gene products: (1) 
extend to Homer2a/b - another CC-Homer isoform critical for the regulation of glutamate transmission [e.g. 
54,56]; (2) are accompanied by changes in their associated glutamate receptor expression and/or the 
activation of downstream kinases [e.g. 12,17,43,47]; (3) persist for 2 weeks following injury indicating their 
role in the maintenance of neuropathic pain; and (4) occur in brain regions involved in nociception 
(thalamus and prefrontal cortex; e.g. [63]).  
The procedures for preparing spinal and supraspinal tissue for subsequent analysis of subcellular distribution 
of proteins was identical to those described previously [15,56,58]. At 1 day, 1 week and 2 weeks following 
CCI, mice were decapitated and the L4-L6 segment of the spinal cord was dissected out over ice and 
subdivided into the ipsi- and contralateral sides of the dorsal horn. Additionally, brains were sectioned (1.0 
mm thick) along the coronal plane and the entire prefrontal cortex and thalamus were dissected out over ice. 
Tissue was placed into 10 volumes of ice-cold homogenization buffer containing: 0.32 mM sucrose, 10 mM 
HEPES at pH=7.4, 5 mM NaF, 1 mM EDTA, with protease inhibitors. The tissue was homogenized using 3-
5 strokes of a glass-teflon homogenizer and spun at 1 000 g for 10 minutes to obtain pellet of nuclei and 
large debris (the P1 nuclear fruction). This pellet (P1) was homogenized in a medium consisting of 0.32 M 
sucrose, 2 mM EDTA, 1% w/v sodium dodecyl sulfate, 50 μM phenyl methyl sulfonyl fluoride, 1 μg/ml 
leupeptin (pH=7.2) and protease inhibitors, and then subjected to low-speed centrifugation at 12 000 g for 
20 min. The remaining supernatants of the P1 fraction (S1) was spun again at 10 000 g for 15 min to obtain 
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a crude synaptosome fraction (P2), and subsequently were lysed hypo-osmticaly in HEPES lysis buffer 
containing 4 mM HEPES, 1 mM EDTA and protease inhibitors and centrifugated at 25 000 g for 20 min to 
pellet synaptosomal membrane fraction (the LP1 PSD fraction). Protein determinations of both P1 and LP1 
fractions were performed using the Bio-Rad DC protein assay (Bio-Rad, Hercules, CA) and homogenates 
were stored at -80
0
C until immunblotting.  
 
Immunoblotting. The immunoblotting procedure quantified P1 and LP1 Homer levels and examined for the 
co-regulation of Homer expression with the Group1 mGluR subtypes mGluR1a and mGluR5, the NR2a and 
NR2b subunits of the NMDA receptor (that link to Homer through a Shank-containing multi-protein 
scaffold; [41,60]), as well as the total and phosphorylated levels of ERK1/2, PI3K and PKC - 3 kinases 
regulated by glutamate receptor activation/Homer expression [e.g. 12,43,47]. Protein samples (10-20 g) 
were subjected to a SDS-polyacrylamide gel electrophoresis. Bis-Tris gradient gels (4-12%) (Invitrogen, 
Carlsbad, CA) were used for separation of Homers, PI3K, and the p(Tyr)p85α PI3K binding motif, the latter 
of which was employed to index PI3K activity. Tris-Acetate gradient gels (3-8%) (Invitrogen, Carlsbad, 
CA) were used for separation of the glutamate receptor proteins. Proteins were transferred to PVDF 
membranes, preblocked with phosphate-buffered saline containing 0.1% (v/v) Tween-20 and either 5% 
(w/v) bovine serum albumin (for p-ERK1/2, pPKCε and for p(Tyr)p85α PI3K binding motif) or 5% (w/v) 
nonfat dried milk powder (for all other proteins) for at least 1 h before overnight incubation with primary 
antibodies. The following rabbit polyclonal antibodies were used: anti-Homer 2a/b and anti-Homer 1b/c (Dr. 
Paul F Worley, Johns Hopkins University School of Medicine; 1:1000 dilution), anti-mGluR5 (Upstate Cell 
Signaling Solutions, Lake Placid, NY; 1:1000 dilution), anti-NR2a and anti-NR2b (Calbiochem, San Diego, 
CA; 1:1000 dilution), anti-PI3K antibody (Upstate, Lake Placid, NY; 1:1000 dilution), and anti-p-(Tyr) 
PI3K p85α binding motif (Cell Signaling Technology, Beverly, MA; 1:250 dilution), anti-ERK1/2 and anti-
pERK1/2 (Santa Cruz Biotechnology, Santa Cruz, CA; 1:500 dilution), anti-PKCε and anti-pPKCε (Santa 
Cruz Biotechnology, Santa Cruz, CA; 1:1000 dilution). An anti-mGluR1a mouse polyclonal antibody 
(Upstate, Lake Placid, NY; 1:1000 dilution). Even loading and transfer were confirmed by probing for 
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calnexin using a rabbit monoclonal antibody (Stressgen, Victoria BC; 1:1000 dilution). Membranes were 
washed and incubated with horseradish-peroxidase-conjugated goat anti-rabbit (Jackson ImmunoResearch 
Laboratories Inc., West Grove PA; 1:10,000-20,000 dilution) or anti-mouse secondary anti-body (Jackson 
Immuno Research Laboratories, West Grove, PA; 1:10,000-1:20,000) for 90 min, and immunoreactive 
bands were detected by enhanced chemiluminescence (ECL Plus; Amersham Biosciences Inc., Piscataway, 
NJ). Immunoreactive levels for all proteins were quantified by integrating band density X area using 
computer-assisted densitometry (Image J; NIH, Betheseda, MD). The density X area measurements for all 
bands were normalized to that of its appropriate calnexin signal to provide a protein/calnexin ratio. The data 
for experimental animals were expressed as a percent change from the mean control signal (n=3-
5/membrane) for each individual membrane. The optical density of the p-ERK1/2, and p-PKCε were divided 
by that of the corresponding total protein band to yield a phospho-protein/total protein ratio prior to 
expressing the data as a percent change from controls.  
 
2.5. Statistical Analysis 
Data analysis and statistical comparisons were performed using GraphPad Prism
TM
, version 4.00 for 
Windows, GraphPad Software, San Diego California USA. Both behavioral and biochemical results are 
presented in the graphs as mean ± SEM. Each group included 8–12 animals. Statistical differences between 
groups in immunoblotting studies were determined by one-way analyses of variance (ANOVA) with 
Tukey’s multiple comparison post-hoc tests. Behavioral results were analyzed by two-way analyses of 
variance (ANOVA) with Bonferroni’s multiple comparison post-hoc tests. Differences within groups 
subjected to the estimation of basal pain threshold were evaluated using unpaired Student’s t test. A value of 




3.1. Sciatic nerve injury up-regulates PSD expression of specific CC-Homer and associated glutamate 
receptor proteins in spinal and supraspinal structures involved in nociception 
Behavior: As expected [42,45], chronic constriction injury (CCI) to the sciatic nerve in B6 mice produced a 
long-lasting (2-week) reduction in pain threshold to mechanical stimuli as demonstrated by the von Frey test 
(2.68 ± 0.09 g for naïve vs. day 2 post-injury: 0.51 ± 0.08 g, day 7 post-injury: 0.53 ± 0.10 g, day 14 post-
injury: 0.57 ± 0.04 g; F(6,63) = 38.60, p<0.001).  
 
Spinal Dorsal Horn: Protein changes induced by CCI were observed within the spinal dorsal horn 
ipsilateral, but not contralateral, to the injury (Fig. 1 vs. Table 1).  
Homers. The increase in pain sensitivity following nerve injury was accompanied by a time-dependent shift 
in the PSD localization of Homer1b/c within the spinal cord ipsilateral to the injury [Time effect: 
F(3,50)=16.57, p<0.0001; Fig. 1A], but no change in Homer1b/c localization within the contralateral dorsal 
horn (Table 1). At 1 day after ligation, Homer1b/c levels were decreased in the PSD fraction from ipsilateral 
dorsal horn, while protein levels were increased by 2-2.5-fold at 1 and 2 weeks post-injury (Fig. 1A). 
Correspondingly, an opposite pattern of change was observed for Homer1b/c expression within the P1 
fraction (Fig. 1B) [t-test between naïve control and 1 week after CCI: t(34)=1.95, p=0.03], supporting that 
sciatic nerve injury elicits a time-dependent increase in Homer1b/c localization within the PSD within dorsal 
horn and this shift in protein localization persists for at least 2 weeks post-injury. In contrast to Homer1b/c, 
Homer2a/b levels within the PSD fraction from ipsilateral dorsal horn exhibited a non-significant (37-46%) 
increase at the later time-points in injured animals (Fig. 1A) and exhibited no pattern of change within the 
P1 fraction (Fig. 1B).  
Glutamate Receptors. While the PSD levels of the glutamate receptor proteins failed to exhibit any 
significant changes early post-injury (at 1 day), mGluR1a, mGluR5 and NR2b expression was elevated at 1 
week post-injury and this effect persisted for NR2b for 2 weeks post-ligation (Fig. 1A) [mGluR1a: 
F(3,45)=3.25, p=0.03; mGluR5: F(3,53)=2.93, p=0.04; NR2b: F(3,52)=5.83, p=0.002]. No changes in the PSD 
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expression of the NR2a subunit were observed [F(3,45)=2.04, p=0.12]. Also, neither mGluR1a/5 nor NR2a/b 
exhibited changes within the P1 fraction at any time (Fig. 1B). These data show for the first time that time-
dependent increases in the localization of Homer1b/c in the PSD within the ipsilateral spinal dorsal horn 
after injury are accompanied by increases in PSD glutamate receptor expression and implicate enduring PSD 
over-expression of Group1 mGluR/NR2b-containing NMDA receptor/Homer1b/c complexes in mediating 
the increased pain sensitivity following sciatic nerve ligation.  
 
Thalamus. The thalamus plays a key role in the transfer of nociceptive information since this structure 
encodes details concerning the type, temporal pattern, intensity and topographic localization of pain [18]. 
Much evidence also suggests that glutamate and glutamate receptors within thalamus are involved in the 
neuronal transmission of pain [19,51]. Thus, we also examined for changes in thalamic expression of 
Homers and their associated glutamate receptors.  
Homers. Thalamic PSD levels of Homer1b/c did not change early post-injury, but were significantly 
elevated 2 weeks post-CCI (Fig. 1C) [F(3,46)=5.07, p=0.01]. The latent increase in LP1 Homer1/c expression 
within thalamus was accompanied by a tendency for reduced protein expression within the P1 fraction 
[compare 1C vs. D; t-test between naïve control and 1 week after CCI: t(33)=2.42, p=0.01]. The injury-
induced changes in thalamic Homer1b/c expression were paralleled by changes in Homer2a/b expression 
with respect to both the increase within the LP1 fraction (Fig. 1C) [F(3,35)=9.92, p<0.0001] and the tendency 
towards a reduction within the P1 fraction [Fig. 1D; t- test between naïve control and 1 week after injury: 
t(33)=1.76, p=0.04; between naïve control and 2 weeks after injury: t(33)=1.86, p=0.04]. These data indicate 
for the first time that the PSD expression of Homer2a/b is also responsive to sciatic nerve injury and that 
injury-induced regulation of the PSD expression of CC-Homer isoforms may be regionally selective within 
central nociceptive pathways.  
Glutamate Receptors. Injury-induced changes in thalamic PSD Homer expression were accompanied by 
increases in the LP1 expression of both Group1 mGluR subtypes, and both the NR2a and NR2b subunits of 
the NMDA receptor (Fig. 1C) [mGluR1a: F(3,43)=5.65, p=0.002; mGluR5: F(3,42)=5.66, p=0.002; NR2a: 
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F(3,39)=3.14, p=0.03; NR2b: F(3,41)=8.46, p=0.0002]. However, only the elevated LP1 levels of NR2b 
persisted for 2 weeks post-injury (Fig. 1C). The tendency towards reduced CC-Homer1/2 expression within 
the P1 fraction from thalamus were accompanied by increases in both mGluR1a and mGluR5 levels, with 
the rise in mGluR5 persisting until the 2-week time-point [mGluR1a: F(3,50)=4.02, p=0.01; mGluR5: 
F(3,56)=9.80, p<0.0001; Fig. 1D]. No changes in P1 levels of either NR2 subunits were observed. While the 
precise subthalamic localization of protein changes cannot be discerned from the present study, these 
immunoblotting data provide novel evidence to support a robust increase in the expression of glutamate 
receptor-Homer complexes within thalamus, which is likely to impinge upon glutamatergic signaling within 
this structure critical for relaying nociceptive information to cortical structures.  
 
Prefrontal cortex. The prefrontal cortex (PFC) is implicated in chronic pain [3,38], in particular in the 
modulation of the emotional and cognitive aspects of nociceptive processing [67]. Also, different Homer 
isoforms play distinct roles in regulating various aspects of glutamate transmission within this forebrain 
structure [33,54].  
Homers. LP1 levels of Homer1b/c were significantly reduced relative to controls at 1 day post-injury and 
this was followed by an elevation in protein expression at the 2 week time-point (Fig. 1E) [F(3,49)=9.01, 
p<0.0001]. While the data presented in Fig. 1F suggested that peripheral nerve injury elicited a transient 
reduction in PFC P1 levels of Homer1b/c, this trend was not significant [F(3,55)=2.68, p=0.06]. In contrast to 
the robust changes in thalamus (Fig. 1C,D), nerve injury failed to alter PFC Homer2a/b levels within either 
the LP1 or the P1 fractions (Fig. 1E,F).  
Glutamate Receptors. The only significant change in PSD glutamate receptor expression was an increase in 
mGluR1a 2 weeks after CCI [F(3,41)=3.50, p=0.02] and this was accompanied by an increase in P1 levels of 
this receptor at the same time-point [F(3,41)=3.50, p=0.02] (Fig. 1 E,F). While no changes were observed for 
the LP1 levels of other glutamate receptor proteins, the P1 levels for mGluR5 and NR2b were reduced at the 
1 day time-point within PFC [mGluR5: F(3,56)=5.69, p=0.002; NR2b: F(3,51)=4.22, p=0.009; Fig. 1F]. These 
data indicate that sciatic nerve ligation does elicit time-dependent and enduring shifts in the subcellular 
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localization of Homer1b/c and its associated glutamate receptors within PFC that is likely to enhance 
glutamatergic signaling within this region [33] in relation to nociception. 
 
3.2. Sciatic nerve injury up-regulates the activity of kinases involved in CC-Homer signal transduction 
within spinal and supraspinal structures involved in nociception  
Stimulation of Group1 mGluRs and NMDA receptors instigates both calcium-dependent and –independent 
intracellular signaling cascades that involve, but are not limited to, activation of PKCs, PI3K and MAP 
kinase pathways [13,14,54]. Moreover, activation of all 3 kinases (or isozymes thereof) under different 
persistent pain states results in the induction and maintenance of pain hypersensitivity [23,66,69]. Thus, we 
immunoblotted further our P1 and LP1 fractions from the spinal dorsal horn, thalamus and PFC for total 
versus phosphorylated PKC, and ERK1/2, as well as total PI3K and phosphorylated p85 binding motif to 
relate our time-dependent changes in glutamate receptor/Homer protein expression (Fig. 1) to the expression 
and activational state of these kinases. 
 
Spinal Dorsal Horn: Injury-induced changes in the levels of total and/or phosphorylated kinases were 
observed within spinal dorsal horn ipsilateral (Fig. 2A and B), but not contralateral, to the injury (Table 1). 
While injury did not alter the expression or phosphorylation state of PKC within the LP1 fraction (Fig. 2A), 
the levels of phospho-PKC and the ratio of phosphorylated vs. total PKC were significantly elevated 
within the nuclear fraction at the 2-week time-point (Fig. 2B) [phospho-PKC: F(3,56)=4.95, p=0.004; PKC 
ratio: F(3,51)=13.06, p<0.0001]. Elevations in the PSD levels of PI3K and of phospho-(Tyr)p85 PI3K 
binding motif (an index of PI3K activation; [74]) were observed at 1 week post-injury (Fig. 2A) [PI3K: 
F(3,51)=3.93, p=0.01; p(Tyr)p85αPI3K binding motif: F(3,48)=3.11, p=0.03]. In contrast to the LP1 fraction, no 
significant changes in PI3K expression or activity were observed within the P1 fraction (Fig. 2B). Finally, 
nerve ligation elevated significantly PSD levels of total, as well as of phospho-ERK1/2 1 week after injury, 
but did not change their relative expression (Fig. 2A) [ERK1/2: F(3,506)=3.57, p=0.02; phospho-ERK1/2: 
F(3,48)=3.73, p=0.02; ERK1/2 ratio: p>0.05]. Together, the data presented in Fig. 2A and B indicate that 
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sciatic nerve injury elicits enduring (1 week) changes in the subcellular distribution and the activational state 
of several kinases within the spinal dorsal horn ipsilateral to the injury.  
We observed an increase in PI3K and ERK1/2 activity at the PSD (LP1 fraction), which co-occurs with 
increases in glutamate receptors and Homer1b/c expression – a finding consistent with a role for Homer 
proteins in regulating glutamate receptor-mediated stimulation of PI3K/MAPK activity [e.g., 12,47]. We 
also observed increases in indices of PKC activation within the nuclear fraction (P1 fraction), which are 
most apparent at times when the levels of glutamate receptors and Homers are normalized within this 
subcellular compartment. These data suggest that time-dependent increases in the PSD expression of 
glutamate receptors and Homer1b/c following nerve injury (Fig. 1A) may facilitate the activation and 
subsequent nuclear translocation of PKC within the spinal dorsal horn, which in turn would be predicted to 
promote the transcription of genes implicated in nociception.   
 
Thalamus. No changes in PSD PI3K expression or activity were observed in thalamus (Fig. 2C), while the 
P1 levels of total PI3K were increased at the 1 and 2-week time-points [PI3K: F(3,54)=9.89, p<0.0001] 
without any change in P1 indices of PI3K activity (Fig. 2D). Total LP1 levels of ERK1/2 and the P1 levels 
of the total and activated ERK1/2 were unchanged by CCI within thalamus (respectively, Fig. 2C,D). 
However, indices of activated ERK1/2 within the PSD fraction of thalamus exhibited a significant reduction 
at 1 day post-injury, followed by increases at the later post-injury time-points [phospho-ERK1/2: 
F(3,54)=3.49, p=0.02; ERK1/2 ratio: F(3,45)=3.09, p=0.04]. The levels of both total and phosphorylated PKC 
were elevated within the LP1 fraction of thalamus at the 1 and/or 2 week time-point (Fig. 2C) [PKC: 
F(3,46)=4.15, p=0.01; phospho-PKC: F(3,45)=6.64, p=0.0008], but the ratio was unchanged. Despite these 
regional differences, we did observe an effect of nerve injury in common between the thalamus and the 
spinal dorsal horn related to nuclear (P1) indices of PKC activation; the levels of phospho-PKCε and the 
ratio of phosphorylated vs. total kinase tended to be low at 1 day post-injury, followed by a large increase in 
expression at the 2-week post-injury time-point (Fig. 2D) [phospho-PKC: F(3,50)=5.23, p=0.003; phospho-
PKC ratio: F(3,46)=4.59, p=0.007]. These data indicate that the development of neuropathic pain 
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hypersensitivity correlates with the activation and nuclear translocation of PKC at both the spinal and 
thalamus levels, as well as increases in ERK1/2 and PI3K signaling that are distinct between these two sites 
of nociception.  
 
Prefrontal cortex: The patterns of change in kinase activity within the PSD fraction from PFC included 
time-dependent increases in the levels of p(Tyr)p85 PI3K binding motif [F(3,49)=4.19, p=0.001], total 
ERK1/2 [F(3,49)=4.51, p=0.007] and phospho-ERK1/2 [F(3,40)=6.18, p=0.001] (Fig. 2E). However, indices of 
PKC activation were reduced within the LP1 fraction at 1 day post-injury (Fig. 2E) [phospho-PKCε ratio: 
F(3,43)=3.06, p=0.04].  Within the P1 fraction indices of PI3K activity were significantly elevated at 2 weeks 
following nerve ligation (Fig. 2F) [F(3,50)=4.24, p=0.009]. The pattern of changes observed for indices of 
PKC activation within the P1 fraction of PFC was completely consistent with those observed for both the 
spinal dorsal horn and the thalamus; the ratio of phosphorylated vs. total PKC exhibited a significant 
reduction at 1 day post-injury followed by a persistent increase (Fig. 2F) [F(3,54)=13.75, p<0.0001]. These 
data for PFC support a potential role for time-dependent changes in the activational state of PI3K, ERK1/2, 
as well as PKC (including its nuclear translocation) in the development and maintenance of neuropathic 
pain following sciatic nerve ligation.   
 
3.3. AAV-mediated over-expression of CC-Homer isoforms exacerbates neuropathic pain 
The proteomic data illustrated in Fig. 1 and 2 implicate a time-dependent up-regulation in endogenous 
glutamate receptor signaling through PKC, PI3K and ERK1/2 at both at the spinal and supraspinal levels of 
the nociceptive pathway following sciatic nerve ligation. The question remains as to the functional 
significance of the injury-induced increases in CC-Homer expression for the development and maintenance 
of neuropathic pain and alterations in basal pain threshold. To address these questions, AAV-Homer1c or 
AAV-Homer2b were intrathecally infused to elevate protein expression within spinal cord (i.e., to mimic the 
effect of peripheral nerve injury on CC-Homer expression; Fig. 1). As illustrated in Fig. 3A and 5A and 
consistent with our earlier reports for AAV-mediated transduction within supraspinal structures [e.g. 12, 
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17,29,33,53,54,56], the local infusion of AAV vectors at the level of L4-L6 produced HA staining. The 
pattern of transduction throughout the dorsal horn of the spinal cord when assessed at 7-8 weeks 
postinfusion indicates for AAVs localization within axons/fibers rather than cell bodies, thus suggesting the 
possibility of further examination of dorsal root ganglia (Fig. 3A). The pattern was very similar to that 
reported previously by Tappe et al. [59] and was not apparent in animals infused with our hrGFP-control 
vector that lacked the HA tag (AAV-control in Fig. 3A and 5A). Thus, we confirmed selective transduction 
of the spinal cord by our AAV infusion procedures that persisted beyond the duration of our behavioral 
studies.  
To mimic the effects of sciatic nerve injury on CC-Homer expression in the spinal cord (Fig. 1A), the first 
behavioral experiment examined if and how AAV-mediated CC-Homer over-expression after spinal 
delivery affects the development and maintenance of neuropathic pain. As expected, control mice exhibited 
a time-dependent and persistent increase in pain hypersensitivity across the 14 days of behavioral testing 
following CCI as measured by the von Frey test (Fig. 3B,D) and by the acetone test (Fig. 3C,E). However, 
both Homer1c and Homer2b over-expressing mice exhibited exacerbated pain hypersensitivity following 
CCI when compared to control animals as: (1) the pain threshold to mechanical stimuli (von Frey filaments) 
was decreased in Homer1c and Homer2b over-expressing mice vs. controls (Fig. 3B,D); (2) for both 
Homer1c and Homer2b over-expressing mice mechanical hypersensitivity increases with the passage of time 
as mechanical pain hypersensitivity in CC-Homer over-expressing mice continued to worsen across the 2 
weeks of testing, while those of control animals stabilized by Day 2 post-injury [AAV-Homer1c: 
F(1,98)=12.33, p=0.0007; AAV-Homer2b: F(1,98)=13.66, p=0.0004]; and (3) both Homer1c and Homer2b 
over-expressing mice exhibited increased sensitivity to acetone, although the magnitude of the differences 
between over-expressing and control AAV mice did not change with the passage of time post-injury [AAV-
Homer1c: F(1,98)=34.07, p<0.0001; AAV-Homer2b: F(1,98)=73.12, p<0.0001]. Thus, the overall pattern of 
change in mechanical and cold hypersensitivity observed following CCI matches, in large part, the profile of 
CCI-induced changes in CC-Homer protein expression within the spinal cord in non-transfected (B6) 
animals (Fig. 3D-E vs. Fig. 1A). 
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Localized transduction after intrathecal delivery of AAV-Homer1c and AAV-Homer2b infusions did not 
alter the basal pain threshold to mechanical stimuli before nerve injury (Fig. 3B,D – Day 0) nor did it alter 
the latency of a separate group of non-injured mice to tail withdrawal (Table 2). Thus, over-expression of 
both CC-Homer1 and CC–Homer2 isoforms increases sensitivity to both mechanical and cold stimuli for at 
least 2 weeks following sciatic nerve ligation – effects that do not reflect changes in basal pain threshold. 
Such data provide the first evidence that CC-Homer isoforms potentiate the development and maintenance 
of neuropathic pain in mice following CCI and pose CCI-induced increases in the spinal cord CC-Homers 
expression as an important mediator of neuropathic pain hypersensitivity.  
 
3.4. Homer1 and Homer2 deletion does not affect neuropathic pain hypersensitivity 
As both CC-Homer1 and CC–Homer2 over-expression after intrathecal delivery potentiated neuropathic 
pain hypersensitivity (Fig. 3) and siRNA-mediated knock-down of Homer1 within the spinal cord was 
shown recently to reduce pain behavior early (4 h) following sciatic nerve ligation [36], we next compared 
mechanical and cold hypersensitivity between injured mice homozygous (KO) and heterozygous (HET) for 
null mutations of Homer1 and Homer2 to their respective wild-type (WT) littermates. The pain behavior of 
WT mice from both lines on a mixed B6-129 background was comparable to that exhibited by inbred B6 
mice in the AAV study (compare Fig. 3 vs. 4). However, no differences were observed between Homer1 
WT, HET and KO genotypes in mechanical (Fig. 4A) and cold sensitivity (Fig. 4B) following nerve injury 
across the 2 weeks of testing. Similarly, no differences were observed between Homer2 WT, HET and KO 
genotypes (Fig. 4C,D). Moreover, no genotypic differences were observed for either KO line regarding their 
basal pain threshold to mechanical stimuli before nerve injury (Fig. 4A, C – Day 0) or tail withdrawal 
latency (Table 2). These data indicate that single deletion of neither Homer1 nor Homer2 alters the 
development and maintenance of pain hypersensitivity following peripheral nerve injury nor does it affect 
basal pain threshold. These data contrast with recent data indicating that intrathecal injection of Homer1 
siRNA alleviates signs of neuropathic pain early post-injury [36]. As Homer2 deletion does not affect CC-
Homer1 expression, at least in supraspinal structures [54], a possible explanation to account for the failure of 
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Homer1 or Homer2 single gene deletions to block neuropathic pain hypersensitivity might relate to 
compensation in scaffolding/signaling by injury-induced increases in the alternate Homer isoform within the 
spinal dorsal horn or supraspinal structures involved in nociception (Fig. 1). Alternatively, developmental 
compensations in glutamatergic signaling within nociceptive pathways, secondary to Homer1 or Homer2 
gene deletion, may mitigate or mask effects of Homer deletion upon pain behavior.   
 
3.5. Transgenic disruption of mGluR5-Homer interactions potentiates neuropathic pain  
Homer proteins physically interact through an EVH1 domain with a proline-rich motif located on the C-
terminus of Group1 mGluRs and this interaction is critical for receptor trafficking and signaling [e.g. 
2,5,6,25-27,61]. Sciatic nerve ligation up-regulates mGluR5 and CC-Homer1/2 expression (Fig. 1), which 
likely increases their probability of physical interaction. The mGluR5 receptor is highly implicated in 
nociception [e.g. 7,16,45,72] and the results of our AAV studies indicate an important role for the spinal 
cord CC-Homer1/2 over-expression in mediating neuropathic pain (Fig. 3). In an attempt to simultaneously 
address the issues of potential Homer1/Homer2 redundancy, as well as potential developmental 
compensations in mGluR5 signaling, for pain processing in our Homer single gene KO mice (Fig. 4), we 
examined the functional relevance of mGluR5-Homer interactions for the development and maintenance of 
neuropathic pain following sciatic nerve ligation by assaying the mechanical and cold sensitivity in a 
transgenic (Tg) mouse with an F1128R point mutation in mGluR5 (mGluR5
F1128R
) reducing the binding of 
Homer proteins [2,12,61]. For this experiment, we compared mice homozygous (Tg) or heterozygous (HET) 
for the transgene to their WT littermates.  
 
WT, HET and Tg mice from the mGluR5
F1128R
 transgenic line (Fig. 5B,C) exhibited a time-dependent 
increase in sensitivity to both mechanical and cold stimuli, but this was augmented by the mutant transgene. 
Tg mice demonstrated significant and persistent exacerbation of sensitivity to von Frey filaments, while the 
phenotype of HET mice was intermediate that of Tg animals and WT controls (Fig. 5B) [Genotype X Time, 
F(12,168)=2.59, p=0.003]. Tg mice also demonstrated exacerbated sensitivity to acetone, but this phenotype 
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was not gene dose-dependent (Fig. 5C) [Genotype effect, F(2,168)=30.59, p<0.0001]. This mutation did not 
reflect changes in basal pain threshold as genotypic differences were not observed for either transgenic line 
regarding basal pain sensitivity to mechanical stimuli before nerve injury (Fig. 5B, D – Day 0) or tail 
withdrawal latency (Table 2). These findings for mGluR5 transgenic mice were quite surprising as they 
indicated that the physical interaction between mGluR5 and CC-Homers normally inhibits or protects 
against the development and maintenance of neuropathic pain following peripheral nerve injury.  
 
3.6. Manipulations of the IEG Homer1 isoform Homer1a alter neuropathic pain  
In addition to the constitutively expressed isoforms Homer1b-g, the Homer1 gene also encodes the IEG 
transcriptional variants Homer1a and ania-3 [e.g. 50,53]. The mRNA and protein levels of Homer1a are 
significantly elevated within the spinal dorsal horn of a model of inflammatory pain [57], as well as during 
the early stage of peripheral nerve injury-induced neuropathic pain, at a time when CC-Homer1 isoforms are 
reduced (Fig. 1; [36,37]). Moreover, functional studies selectively targeting Homer1a indicate that spinal 
cord over-expression of Homer1a protects against, while Homer1a knock-down with shRNA exacerbates, 
symptoms of inflammatory pain [57]. Thus, we tested the hypothesis that Homer1a deletion would also 
exacerbate the development and maintenance of neuropathic pain following peripheral nerve injury.  
 
We first employed a Homer1a KO strategy [21] to determine whether or not preventing the induction of 
Homer1a post-sciatic nerve injury [36,37] would exacerbate the development and maintenance of 
neuropathic pain. In support of our hypothesis, a comparison of Homer1a WT, HET and KO mice indicated 
a significant potentiation of sciatic nerve injury-induced pain hypersensitivity in mutant animals (Fig. 5D,E). 
Persistent genotypic differences were observed across the 2 weeks of testing with both mechanical (Fig. 5D) 
[Genotype effect: F(2,168)=39.89, p<0.0001] and cold hypersensitivity increased in KO mice, relative to WT 
and HET animals (Fig. 5E) [Genotype effect: F(2,168)=25.38, p<0.0001]. The exacerbated pain 
hypersensitivity observed in Homer1a KO animals following injury did not reflect changes in basal pain 
threshold in the responses to mechanical stimuli before CCI (Fig. 5D – Day 0) or in tail withdrawal latency 
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(Table 2). Thus, Homer1a induction is not necessary for basal pain threshold, but inhibits the development 
and maintenance of neuropathic pain following peripheral nerve injury, in a manner consistent with the 
notion that Homer1a induction is anti-nociceptive [57].  
 
Next, we assessed the effects of spinal cord Homer1a over-expression via intrathecal infusions of an AAV 
carrying Homer1a cDNA [30,57] to determine whether or not Homer1a over-expression protected against 
the development and maintenance of pain hypersensitivity following CCI. AAV-mediated Homer1a over-
expression after intrathecal delivery (Fig. 5A) completely blocked the development and maintenance of 
mechanical hypersensitivity post-injury examined by von Frey testing (Fig. 5F) [AAV X Time: 
F(6,126)=15.23, p<0.0001]. Homer1a over-expression also significantly reduced the enhanced cold 
hypersensitivity in the acetone test (Fig. 5F) [AAV X Time: F(6,126)=21.51, p<0.0001], but did not affect 
basal pain threshold when assessed in the tail flick test (Table 2) or upon mechanical stimulation before 
injury (Fig. 5F – Day 0). These data provide the first evidence that the induction of Homer1a within the 
spinal cord following peripheral nerve injury inhibits the development and maintenance of neuropathic pain. 
These observations extend earlier findings obtained for inflammatory pain [58] and further support the 
hypothesis put forth by Tappe and colleagues [58] that Homer1a induction may serve as a negative regulator 




The present report provides in vivo insight into the functional involvement of different Homer isoforms, and 
their interaction with mGluR5, in the development and maintenance of neuropathic pain, thereby extending 
previous indications of an important role for Homer1 gene products in regulating pain sensitivity 
[36,37,40,57,71].  
 
4.1. Nerve injury co-regulates CC-Homers and associated receptors/kinases 
Nerve injury-induced increases in glutamate receptors [10,24,48,65], the activity of PKC, PI3K/MAP 
kinases [66,69], and Homer1 expression [36,37,40] putatively contribute to the development of neuroplastic 
changes associated with chronic pain. Consistent with this, Homer1b/c, as well as its associated glutamate 
receptors (mGluR1a/5) and downstream kinases (PKC, PI3K, ERK1/2), were time-dependently up-
regulated within both spinal and supraspinal nociceptive structures after sciatic nerve ligation (Fig. 1 and 2), 
in a manner temporally correlated with the expression of fully developed mechanical and cold 
hypersensitivity (e.g., Fig. 3). However, injury-induced increases in PSD Homer2a/b expression were 
observed only within thalamus (Fig. 1C). This novel finding indicates that Homer2a/b levels, at least within 
thalamus, are responsive to nerve injury and suggests that glutamate sensitization within thalamus, 
specifically involving Homer2a/b, may be additionally implicated in mediating neuropathic pain. While the 
functional relevance of supraspinal changes in CC-Homer1/2 expression requires further investigation, 
thalamic co-regulation of both CC-isoforms implicates a shared role in pain perception. Thalamic and spinal 
nociceptive neurons sensitize to mechanical and cold stimuli during peripheral neuropathy [18,19,63], 
posing an exclusive and non-exclusive role for Homer1b/c in the regulation of injury-induced glutamate 
sensitization within, respectively, spinal dorsal horn and thalamus. This being proposed, Homer2b over-
expression exacerbated neuropathic pain symptoms in a manner qualitatively and quantitatively similar to 
Homer1c over-expression (Fig. 3). Thus, despite their differential regional regulation following injury, CC-
Homer1 and 2 isoforms appear to be interchangeable with respect to pain perception at least at the spinal 
cord level.  
  
24 
Whether or not the injury-induced increased activation of PKC, PI3K and/or ERK1/2 throughout the 
nociceptive network requires intact interactions between Homers and glutamate receptors and whether or not 
neuropathy-induced elevations in kinase activity might contribute to injury-induced changes in 
receptor/Homer expression remains to be determined. Supporting these possibilities, the co-activation of 
Group1 mGluRs and NMDARs stimulates ERK1/2 activation in a Homer-dependent manner [70] and the 
capacity of Group1 mGluRs and NMDARs to increase intracellular calcium and to activate MAP kinase 
pathways are both prevented by Homer1a over-expression [57]. Moreover, blocking NMDARs or ERK1/2 
activity prevents the transient rise and drop, respectively, in the spinal dorsal horn Homer1a and/or 
Homer1b/c levels early post tissue or nerve injury [36,40,57]. Proline-directed kinases, such as ERK1/2, 
phosphorylate mGluR1/5 within the Homer binding domain [44] (Park JM, Hu JH, Milshteyn A, Zhang PW, 
Moore CG, Park S, Datko MC, Domingo RC, Reyes CM, Wang XJ, Etzkorn FA, Xiao B, Szumlinski KK, 
Kern D, Linden DJ, Worley PF. A prolyl-isomerase mediates dopamine-dependent plasticity and cocaine 
motor sensitization. Cell (submitted for publication)) and this increases the avidity of the receptor for Homer 
[44,47]. Moreover, CC-Homer multimerization and binding to Group1 mGluRs occludes their respective 
PEST (proline, glutamate, serine, threonine) sequences and reduces their ubiquitin-mediated degradation 
[11,20,39]. Thus, we suggest that nerve injury-induced stimulation of PKC and/or PI3K/MAPK signaling 
pathways (likely secondary to glutamate receptor stimulation) may induce transcription of Homer genes, 
instigating an abhorrent feed-forward process of enhanced protein production and protein-protein 
interactions, which enhances synaptic efficacy at all levels of the nociceptive network and exaggerates pain 
hypersensitivity following nerve injury.  
 
4.2. Distinct functional roles for CC-Homer and IEG-Homer proteins in neuropathic pain 
Indeed, mGluR/NMDAR antagonists [e.g. 1,8,10,34,45,48,60], spinal cord Homer1 knock-down [36,71] and 
spinal cord Homer1a over-expression [57], all inhibit pain sensitivity in various pain models. Consistent 
with these observations, spinal cord CC-Homer over-expression exacerbated (Fig. 3), while Homer1a over-
expression inhibited, nerve injury-induced pain hypersensitivity (Fig. 5D-G) and none of our manipulations 
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influenced basal pain threshold when assessed in the tail withdrawal test (Table 2). Thus, CC-Homer and 
IEG-Homer isoforms display divergent functional roles in the regulation of tissue or nerve injury-induced 
hypersensitivity. 
 The observation that mGluR5 Tg mice exhibited heightened neuropathic pain symptoms akin to those 
produced by Homer1a deletion (Fig. 5) is intriguing in light of recent evidence that these two mouse lines 
exhibit opposite inflammatory pain phenotypes, with the mGluR5 Tg mice exhibiting an exacerbation of 
symptoms consistent with Homer2/Homer3 double-KO mice [22]. Such findings, coupled with the evidence 
herein that none of our manipulations influenced basal pain threshold, argue against a simple model of 
Homer-mGluR5 in pain perception.  Further supporting this argument, neither Homer1 nor Homer2 deletion 
influenced pain hypersensitivity in neuropathic pain (Fig. 4), despite siRNA evidence that Homer1 gene 
products within the spinal cord are required for the development of neuropathic pain hypersensitivity early 
post-injury [36]. Given our AAV-cDNA results (Fig. 3) and the fact that Homer2/Homer3 double-KO mice 
exhibit an inflammatory pain phenotype [22], it seems that developmental compensation secondary to single 
Homer gene deletion or redundancy in Homer function may have masked or altered the neuropathic pain 
phenotype of the KO mice in this study. Alternatively, the lack of an effect of single Homer gene deletion in 
Homer1 and Homer2 KO mice might also relate to their differences in: (1) encoding of IEG isoforms [c.f. 
50]; (2) affinity for Group1 mGluRs [25]; (3) effects upon NMDAR subunit expression and function [c.f. 
55]; and/or (4) the ability to regulate extracellular glutamate levels within spinal cord, PFC [25,54,56], and 
perhaps within other nociception-related CNS structures. Regardless, our data for Homer1a KO mice, 
together with our collection of AAV-cDNA results, speak to distinct roles for different Homer gene products 
in regulating neuropathic pain and indicate that nerve injury-induced increases in CC-Homer expression are 
important, but not critical, for the development and maintenance of neuropathic pain.  
 
The available in vitro literature indicates comparable effects of mGluR5
F1128R
 mutation and Homer1a over-
expression upon receptor signaling [e.g. 2,21]. While constitutive mGluR5 activity, which is CC-Homer-





mutants, it is not is not likely to mediate pain hyper-sensitivity in Homer1a KO mice as Homer1a induction 
stimulates constitutive receptor activity [2], but is consistently anti-nociceptive [57; Fig. 5].  The similar 
behavioral phenotype of mGluR5 Tg and Homer1a KO mice (Fig. 5) may be explained in several ways. 
First, interactions between mGluR5/Homer1a rather than mGluR5/CC-Homers within spinal cord may 
critically mediate neuroplastic changes related to pain hypersensitivity. This further suggests that nerve 
injury-induced induction of IEG-Homer1a and its consequent binding to mGluR5 protects against and plays 
dominant roles in the development and maintenance of neuropathic pain. However, Homer1 deletion 
prevents the induction of IEG Homer1 gene products, yet Homer1 KO mice (that lack both IEG and CC-
Homer1 isoforms) exhibited no obvious neuropathic pain phenotype following nerve injury (Figure 4).  
Alternatively, given the wealth of evidence for NMDA receptors [e.g. 10,31,38,64] and mGluR1 [e.g. 
1,8,34] in mediating pain, intact signaling through either of these receptors, or perhaps some other signaling 
pathway(s),  may be sufficient to maintain nociception in the mGluR
F1128R
 mutants and could potentially be 
enhanced by virtue of the fact that CC-Homers are unable to bind to mGluR5 in the Tg mice. Third, other 
proteins with PDZ binding domains (e.g. NHERF-2 or Tamalin) [28,46] may be able to scaffold and 
maintain signaling through mGluR5, in the absence of Homer binding, and thus, mediate the pain phenotype 
of the Tg mice.  
 
4.3. Hypothetical mechanisms underlying Homer’s role in chronic pain 
The mechanisms through which nerve injury-induced changes in CC-Homer expression exacerbate 
neuropathic pain are putatively related to CC-Homer’s ability to regulate the signaling pathways activated 
upon Group1 mGluR and NMDA stimulation [e.g. 25-27,47,70]. CC-Homers link Group 1 mGluRs to 
intracellular calcium stores via scaffolding with the IP3 receptor and facilitate the integration of calcium 
signals elicited by Group1 mGluR and NMDA receptor stimulation by virtue of binding to the NMDA-
associated scaffolding protein Shank [c.f. 65]. In contrast, the transient and rapid induction of IEG-Homer1a 
uncouples CC-Homers from NMDA receptor/Shank and Group1 mGluRs and facilitates mGluR interactions 
with ion channels [e.g. 26,27]. Nerve or tissue injury-induced Homer1a induction in the spinal cord appears 
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to influence NMDAR-dependent calcium entry and reduces the efficiency of Gq signaling (including 
MAPK activation), as well as the number of synaptic contacts on spinal cord neurons that process pain input 
[36,40,57]. Moreover, CC-Homers, in particular Homer2 isoforms, normally occlude Group1 mGluR 
inhibition of certain voltage-gated calcium channels [e.g., 26] and Homer1a over-expression, presumably 
such as that induced by injury/pain [35-37,40], can remove this occlusion, facilitate mGluR-calcium channel 
interactions and inhibition of calcium entry/neuronal transduction [5,25,27,62]. Either, or both, of these 
mechanisms may be proposed to account for the bi-directional effect of manipulating Homer1a expression 
upon nociception. However, in the WT animal, the accumulation of Homer1a in the PSD of spinal cord 
following nerve injury is transient [36,40].  While an increase in Homer1a expression clearly protects 
against the behavioral signs of neuropathic pain (Fig. 5C), it may also permit enhanced PSD trafficking of 
both Group1 mGluRs and NMDA receptors, as well as CC-Homers and ultimately augment the cross-talk 
between these receptors within the PSD [68]. While we did not examine for injury-induced changes in the 
PSD localization of glutamate receptors and Homers within the nociception pathway in mGluR5
F1128R
 
mutant animals, the exacerbation of pain produced by the F1128R mutation of mGluR5 (Fig. 5A) would 
suggest increased glutamate receptor cross-talk, which is a finding in line with recent electrophysiological 
evidence indicating that the mGluR5
F1128R
 mutation augments brain-derived neurotrophic factor-mediated 
activation of NMDA receptor currents in the absence of Homer1a induction (Park JM, Hu JH, Milshteyn A, 
Zhang PW, Moore CG, Park S, Datko MC, Domingo RC, Reyes CM, Wang XJ, Etzkorn FA, Xiao B, 
Szumlinski KK, Kern D, Linden DJ, Worley PF. A prolyl-isomerase mediates dopamine-dependent 
plasticity and cocaine motor sensitization. Cell (submitted for publication)). Thus, while not assayed directly 
in the present study, potential long-term Homer1a-mediated synaptic remodeling changes within PSD may 
paradoxically heighten signaling through glutamate receptor/CC-Homer complexes and eventually 
contribute to the development of neuropathic pain hypersensitivity.  
 
In conclusion, here we showed that the dynamic but temporally distinct regulation of both IEG and CC-
Homer isoforms contribute to long-lasting increases excitatory synaptic efficacy that underlies the 
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development and maintenance of neuropathic pain. Moreover, the induction of the IEG-Homer1a isoform 
may serve acutely to inhibit neuropathic pain hypersensitivity but facilitate synaptic rearrangement that 
promotes pain sensitivity in the long-term. Thus, time-dependent and selective targeting of Homer 
expression within the spinal cord may underlie the successful therapeutic intervention in chronic long-
lasting pain.   
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Fig. 1 Chronic constriction injury (CCI) of the sciatic nerve produces time-dependent changes in CC-
Homers and glutamate receptors expression mainly within the PSD (LP1; A, C, E), than within the P1 
(nuclear and large debris) fraction (B, D, F) of the ipsilateral spinal dorsal horn (A-B), thalamus (C-D) and 
prefrontal cortex (E-F). Each graph represents summary of the change in protein expression obtained 1, 7 
and 14 days after the CCI and expressed as a percentage of the average protein expression of the naïve 
controls. Data are presented as mean ± SEM, n=10-12 of B6 mice per each experimental group. The 
intensity of the bands for each antibody was normalized with the intensity of its appropriate calnexin signal. 
The asterisk (*) denotes significance vs. naïve controls; 
*
p<0.05 (one-way ANOVA, followed by Tukey’s 
comparison post-hoc test). Representative immunoblots correspond to the total protein levels of Homer1b/c, 
Homer2a/b, mGluR1a, mGluR5, NR2a and NR2b.  
 
Fig. 2 Chronic constriction injury (CCI) of the sciatic nerve elevates protein expression of the members of 
the PI3K/MAPK signaling pathway mainly 1 and/or 2 weeks after the injury within the PSD (LP1; A, C, E) 
and the P1 fraction (B, D, F) of the ipsilateral spinal dorsal horn (A-B), thalamus (C-D) and prefrontal 
cortex (E-F). Each graph represents summary of the change in protein expression obtained 1, 7 and 14 days 
after the CCI and expressed as a percentage of the average protein expression of the naïve controls. Data are 
presented as mean ± SEM, n=10-12 of B6 mice per each experimental group. The intensity of the bands for 
each antibody was normalized with the intensity of its appropriate calnexin signal. The asterisk (*) denotes 
significance vs. naïve controls; 
*
p<0.05 (one-way ANOVA, followed by Tukey’s comparison post-hoc test). 
Representative immunoblots correspond to the total protein levels of PKCε, phospho- PKCε, PI3K, 
phospho(Tyr)p85α PI3K binding motif [p(Tyr)p85α], ERK1/2 and phospho-ERK1/2.  
 
Fig. 3 AAV-mediated over-expression of CC-Homer isoforms potentiates neuropathic pain hypersensitivity. 
(A) Representative images of green fluorescent protein (hrGFP) epifluorescence (AAV-control vector) or 
immunostaining for the HA tag (AAV-Homer1c and –Homer2b cDNA vectors) using a specific antibody on 
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L4-L6 spinal dorsal horn sections (80 μm) at 7-8 weeks after AAV infusion. HA staining was conducted 
also on spinal cord tissue from AAV-control animals as a control for non-specific staining. Scale bar = 200 
μm. (B-E) AAV-mediated overexpression of two CC-Homer isoforms, Homer1c (B-C) and Homer2b (D-E), 
within the spinal cord exacerbates the injury-induced mechanical (B, D) and cold (C, E) hypersensitivity in 
neuropathic pain. AAV-Homer1c and AAV-Homer2b were injected intrathecally in B6 mice. Mechanical 
sensitivity was assessed using von Frey filaments; cold sensitivity was determined by the acetone test. The 
measurements were assessed before chronic constriction injury (CCI) of the sciatic nerve and then every 2
nd
 
day for 2 weeks following the injury. The same control group was used in B and C, as well as in C and E. 
Data are presented as means ± S.E.M, n = 8-10 in each group. The asterisk (*) denotes significance vs. 
control; 
*
p<0.05 (two-way ANOVA, followed by Bonferroni’s comparison post-hoc test). 
 
Fig. 4 Deletion of Homer1 and Homer2 does not affect the development and maintenance of neuropathic 
pain. Each graph demonstrates mechanical (A, C) or cold (B, D) hypersensitivity induced by chronic 
constriction injury (CCI) of the sciatic nerve in Homer1 and Homer2 gene knock-out mice (KO), 
heterozygous (HET) and wildtype controls (WT). Mechanical sensitivity was assessed using von Frey 
filaments; cold sensitivity was determined by the acetone test. The measurements were assessed before CCI 
and then every 2
nd
 day for 2 weeks following the injury. Data are presented as means ± S.E.M, n = 10-12 in 
each group. The asterisk (*) denotes significance vs. WT; 
*
p<0.05 (two-way ANOVA, followed by 
Bonferroni’s comparison post-hoc test).  
 
Fig. 5 Homer1a protects against mechanical and cold hypersensitivity following chronic constriction injury 
(CCI) of the sciatic nerve. (A) Representative images of immunostaining for the HA tag (AAV-Homer1a 
cDNA vectors) using a specific antibody on L4-L6 spinal dorsal horn sections (80 μm) at 7-8 weeks after 
AAV infusion. HA staining was conducted also on spinal cord tissue from AAV-control animals as a control 
for non-specific staining. Scale bar = 200 μm. (B-G) Each graph demonstrates mechanical and cold 
hypersensitivity induced by CCI in transgenic
 





 (B-C), in Homer1a gene knock-out mice (KO), heterozygous (HET) and their respective 
wildtype controls (WT) (D-E), and in B6 mice after intrathecal injection of AAVs carrying Homer1a (F-G). 
Mechanical sensitivity was assessed using von Frey filaments; cold sensitivity was determined by the 
acetone test. The measurements were assessed before CCI and then every 2
nd
 day for 2 weeks following the 
injury. Data are presented as means ± S.E.M, n = 10-12 in each group. The asterisk (*) denotes significance 
vs. WT/control; 
*





Table 1  
Summary of the lack of statistically significant changes in the protein expression of members of the Homers-
glutamate receptors-PI3K/MAPK kinases signalling pathway induced by chronic constriction injury of the 
sciatic nerve evaluated through immunoblotting within membrane (LP1) and nuclear (P1) fractions of the 
contralateral spinal dorsal horn 1 day, 1 week and 2 weeks following nerve injury. P(Tyr)p85α is 
abbreviation for phospho-(Tyr)p85αPI3K binding motif. The values were determined by one-way ANOVA 
followed by Tukey’s comparison post-hoc test. Each group included 8–12 animals. 
 
 LP1  P1  
Homer1b/c F(3,44)=1.13  P=0.34 F(3,39)=0.07  P=0.98 
Homer2a/b F(3,36)=1.49  P=0.23 F(3,52)=0.21  P=0.89 
mGluR1a F(3,46)=0.62  P=0.61 F(3,50)=0.57  P=0.64 
mGluR5 F(3,48)=0.34  P=0.79 F(3,56)=0.89  P=0.45 
NR2a F(3,45)=0.31  P=0.82 F(3,56)=0.77  P=0.51 
NR2b F(3,41)=0.18  P=0.91 F(3,50)=0.54  P=0.66 
PKCε F(3,47)=2.76  P=0.06 F(3,55)=1.56  P=0.21 
pPKCε F(3,39)=0.06  P=0.98 F(3,56)=1.01  P=0.39 
Ratio pPKCε F(3,37)=0.19  P=0.89 F(3,56)=1.03  P=0.39 
PI3K F(3,49)=0.45  P=0.71 F(3,50)=0.75  P=0.53 
P(Tyr)p85α F(3,35)=0.52  P=0.67 F(3,50)=0.05  P=0.98 
ERK1/2 F(3,51)=0.46  P=0.71 F(3,51)=0.99  P=0.40 
pERK1/2 F(3,43)=0.41  P=0.75 F(3,51)=1.44  P=0.24 






Summary of the mean ± SEM of the basal pain threshold for control and AAV-treated mice as well as for 
wildtypes (WT), heterozygous (HET) and Homer1, Homer2, Homer1a gene knock-out (KO) mice and 
mGluR5
F1128R
 transgenic mice (Tg) with disrupted Homer-mGluR5 binding. The basal pain threshold was 
measured in the hot (54°C) water tail-immersion assay. Each group included 10-12 animals. The last column 
shows no statistically significant changes within groups as determined by one-way ANOVA followed by 
Bonferroni’s comparison post-hoc test.  
 
 control/WT HET AAV/KO/Tg  
AAV-Homer1c 2.63 ± 0.10 - 2.62 ± 0.19 t(14)=0.06 P=0.95 
AAV-Homer2b 2.63 ± 0.10 - 2.47 ± 0.10 t(14)=1.10 P=0.29 
AAV-Homer1a 2.63 ± 0.10 - 2.69 ± 0.23 t(14)=0.23 P=0.82 
Homer1 2.81 ± 0.14 2.80 ± 0.09 2.84 ± 0.06 F(2,35)=0.03 P=0.97 
Homer2 3.03 ± 0.12 3.24 ± 0.13 3.01 ± 0.08 F(2,31)=1.16 P=0.33 
mGluR5
F1128R
 2.72 ± 0.11 2.76 ± 0.12 2.96 ± 0.17 F(2,34)=0.87 P=0.43 
Homer1a 2.90 ± 0.10 2.82 ± 0.12 2.84 ± 0.10 F(2,26)=0.17 P=0.84 
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